Signaling pathways in pancreatic cancer

Meir Preis, Murray Korc

Research output: Contribution to journalReview articlepeer-review

26 Scopus citations


Pancreatic ductal adenocarcinoma (PDAC) is a deadly malignancy characterized by a plethora of molecular alterations that include major and minor driving mutations, the presence of intense desmoplasia exhibiting numerous proliferating pancreatic stellate cells (PSC) and cancer-associated fibroblasts that produce fibronectin and collagens, and foci of inflammatory cells that produce mitogenic cytokines. This review will focus on signaling by tyrosine kinase receptors, and the role of transforming growth factor beta in this malignancy is described briefly. Potential for therapeutic interventions will be discussed in relation to specific pathways.

Original languageEnglish (US)
Pages (from-to)115-129
Number of pages15
JournalCritical Reviews in Eukaryotic Gene Expression
Issue number2
StatePublished - Jan 1 2011


  • Pancreatic cancer
  • Signaling
  • Tyrosine kinase receptors

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Fingerprint Dive into the research topics of 'Signaling pathways in pancreatic cancer'. Together they form a unique fingerprint.

Cite this